 Connection
John Imig to Cyclooxygenase 2 Inhibitors
This is a "connection" page, showing publications John Imig has written about Cyclooxygenase 2 Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.535 |
|
|
|
-
Hye Khan MA, Goorani S, Atamanchuk A, Jankiewicz W, Yeboah MM, Barnett SD, Falck JR, Hwang SH, Barnych B, Hammock BD, El-Meanawy A, Imig JD. Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice. Eur J Pharmacol. 2025 Nov 05; 1006:178132.
Score: 0.966
-
Hye Khan MA, Hwang SH, Sharma A, Corbett JA, Hammock BD, Imig JD. A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat. Prostaglandins Other Lipid Mediat. 2016 09; 125:40-7.
Score: 0.512
-
Dey A, Maric C, Kaesemeyer WH, Zaharis CZ, Stewart J, Pollock JS, Imig JD. Rofecoxib decreases renal injury in obese Zucker rats. Clin Sci (Lond). 2004 Dec; 107(6):561-70.
Score: 0.057
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|